Lineage Cell Therapeutics
(AMEX:LCTX)
$1.25
0.05[4.17%]
Last update: 9:28AM Get Real Time Here
OverviewNewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest

Lineage Cell Therapeutics Stock (AMEX:LCTX), Quotes and News Summary

Lineage Cell Therapeutics Stock (AMEX: LCTX) stock price, news, charts, stock research, profile.

Open-
Close-
Volume / Avg.1.549K / 951.499K
Day Range- - -
52 Wk Range0.841 - 1.610
Market Cap$235.667M
P/E Ratio-
Dividend Yield-
ExchangeAMEX
RSI
45
Short Interest
7.43%
Days to Cover8.88

Recent News

Lineage Cell Therapeutics, Longeveron And 2 Other Stocks Under $2 Insiders Are Buying
The Dow Jones index closed higher by around 25 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Avi Kapoor
EXCLUSIVE: Cell Therapy Player Lineage Cell Therapeutics Starts Development Activities Under Licensing Pact With Eterna Therapeutics
Lineage Cell Therapeutics Inc (NYSE: LCTX) has initiated certain development activities to generate a novel hypoimmune induced pluripotent stem cell (iPSC) line under the company’s exclusive option and license agreement with Eterna Therapeutics Inc (NASDAQ:
Vandana Singh
Why DLocal Shares Are Trading Higher By 25%; Here Are 20 Stocks Moving Premarket
Gainers
Lisa Levin
-%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trend
2
Feb
1
Mar
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
4.3
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
About Lineage Cell Therapeutics Inc
Sector
Health Care
Industry
Biotechnology
Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development a...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
LCTX
IPHA

FAQ

Q

How do I buy Lineage Cell Therapeutics (LCTX) stock?

A

You can purchase shares of Lineage Cell Therapeutics (AMEX: LCTX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Lineage Cell Therapeutics's (LCTX) competitors?

A

Other companies in Lineage Cell Therapeutics’s space includes: Innate Pharma (NASDAQ:IPHA), Galectin Therapeutics (NASDAQ:GALT), Adverum Biotechnologies (NASDAQ:ADVM), Inovio Pharmaceuticals (NASDAQ:INO) and Adaptimmune Therapeutics (NASDAQ:ADAP).

Q

What is the target price for Lineage Cell Therapeutics (LCTX) stock?

A

The latest price target for Lineage Cell Therapeutics (AMEX: LCTX) was reported by HC Wainwright & Co. on Friday, March 8, 2024. The analyst firm set a price target for 7.00 expecting LCTX to rise to within 12 months (a possible 460.00% upside). 8 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Lineage Cell Therapeutics (LCTX)?

A

The stock price for Lineage Cell Therapeutics (AMEX: LCTX) is $1.25 last updated Today at April 19, 2024 at 9:28 AM EDT.

Q

Does Lineage Cell Therapeutics (LCTX) pay a dividend?

A

There are no upcoming dividends for Lineage Cell Therapeutics.

Q

When is Lineage Cell Therapeutics (AMEX:LCTX) reporting earnings?

A

Lineage Cell Therapeutics’s Q1 earnings are confirmed for Thursday, May 9, 2024.

Q

Is Lineage Cell Therapeutics (LCTX) going to split?

A

There is no upcoming split for Lineage Cell Therapeutics.

Q

What sector and industry does Lineage Cell Therapeutics (LCTX) operate in?

A

Lineage Cell Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.

People Also Watch